Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Neptune Wellness Solutions Inc NEPTF

Neptune Wellness Solutions Inc. is a consumer-packaged goods company that is primarily focused on health and wellness products. The Company focuses on developing a portfolio of consumer products that align with the market trends for natural, sustainable, plant-based, and purpose-driven lifestyle brands. Its products are available in more than 29,000 retail locations and include organic food and beverage brands, such as Sprout Organics, Nosh, and Nurturme, as well as nutraceuticals brands like Biodroga and Forest Remedies. Its main brand units are nutraceuticals and organic foods and beverages. The Company sells its nutraceutical products mainly in bulk soft gels or liquids to multiple distributors and customers, who commercialize these products under their private label. The Company, through its Sprout subsidiary, sells its organic foods and beverages products to mass retailers, grocery stores and other retail outlets, as well as online through e-commerce sites and its own Website.


GREY:NEPTF - Post by User

Post by goldstoryon Oct 23, 2014 10:43am
504 Views
Post# 23054184

Acasti's Phase III trial, stock buy back, and etc.

Acasti's Phase III trial, stock buy back, and etc.I listened the recent conference call again and have the following questions.  If you have the knowledge, please post it.

1.  The detail explanation for the decision that Acasti decided to go alone for Phase III was deferred to the Acasti's BOD.  Was there any conference call from Acasti after that?   If not, when will be there one?    I am wondering if Acasti's decision was due to the lack of interests from the big pharma or not.

2.  It was said that the new CEO will be announced by the end of Nov.   Will he be the new CEO for the Acasti too?  

3.  I see the 3M shares of short interest on Neptune by 9/30.  Does anyone have real time info about this?   What is the date they should cover?

Thanks.



Bullboard Posts